netFormulary Bradford Teaching Hospitals NHS
NHS Foundation Trust Formulary  
 Formulary Chapter 18: Emergency Treatment of Poisoning - Full Chapter
Chapter Links...
18  Expand sub section  Poisoning
18  Expand sub section  Body Temperature
18  Expand sub section  Nerve agents
18  Expand sub section  Pesticides
18  Expand sub section  Snake bites and animal stings to top
18  Expand sub section  Convulsion
18  Expand sub section  Removal and Elimination
18  Expand sub section  Removal from the Gastro-intestinal tract
18  Expand sub section  Prevention of absorption
18  Expand sub section  Active elimination techniques to top
18  Expand sub section  Specific Drugs
18  Expand sub section  Alcohol
18  Expand sub section  Analgesics (non-opioid)
18  Expand sub section  Analgesics (opioid)
18  Expand sub section  Antidepressants to top
18  Expand sub section  Antimalarials
18  Expand sub section  Beta Blockers
18  Expand sub section  Calcium-channel blockers
18  Expand sub section  Hypnotics and anxiolytics
18  Expand sub section  Iron Salts to top
18  Expand sub section  Lithium
18  Expand sub section  Phenothiazines and related drugs
18  Expand sub section  Stimulants
18  Expand sub section  Theophylline
18  Expand sub section  Other poisons to top
18  Expand sub section  Cyanides
18  Expand sub section  Ethylene glycol and methanol
18  Expand sub section  Heavy Metals
18  Expand sub section  Noxious gases
18  Expand sub section  CS Spray to top
 Non Formulary Items
Calcium chloride

View adult BNF View SPC online View childrens BNF
Non Formulary
Calcium gluconate

View adult BNF View SPC online View childrens BNF
Non Formulary
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Track Changes
Display tracking information
click to search
Link to adult BNF
click to search
Link to children's BNF
click to search
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHS England

Traffic Light Status Information

Status Description


Medicines suitable to be prescribed in primary care after Specialist* recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust D&TC(s). *Specialist is defined as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice.   

Amber 1

Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (D&TC) * All drugs awaiting the production or approval of a shared care guideline default to RED   

Cancer Drug Fund

Cancer Drug Fund   


Medicines suitable for routine use and can be prescribed within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.  

Green Specialist Initiation

These drugs should be initiated only by a hospital or specialist clinician (GPSi) but there is no requirement for additional monitoring over the general requirements for all medicines. Some may require short or medium specialist monitoring of efficacy or dose titration before transferring in Primary care. The GP should have all the information they require to support continued prescribing.   

Green Specialist Recomendation



Grey - Medicines, which the Drug & therapeutics Committee has actively reviewed and does not recommend for use at present following a review of clinical and/or cost effective data. Grey (assessment in progress) - will be reviewed at a future D&T meeting. Grey (awaiting submission) - The D&T are awaiting a submission from an appropriate practitioner. If you wish to make a submission for this medicine to be added to the formulary please email .   

Non Formulary

Not recommended for prescribing as initial therapy, but can be continued if patient already stable on treatment   


Medicines which should normally be prescribed by specialists only. ** For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care   


Unlicensed Medication